Consenso SEEDO 2007 para la evaluación del sobrepeso y la obesidad y el establecimiento de criterios de intervención terapéutica MA Rubio, J Salas-Salvadó, M Barbany, B Moreno, J Aranceta, D Bellido, ... Rev Esp Obes 5 (3), 135-75, 2007 | 1084* | 2007 |
Age-and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts J Tuomilehto, J Lindstrom, S Keinanen-Kiukaanniemie, L Hiltunen, ... Diabetes Care 26 (1), 61-69, 2003 | 724* | 2003 |
Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA) A Mestrón, SM Webb, R Astorga, P Benito, M Catalá, S Gaztambide, ... European Journal of Endocrinology 151 (4), 439-446, 2004 | 562 | 2004 |
Documento de consenso para la detección y manejo de la enfermedad renal crónica A Martínez-Castelao, JL Górriz, J Bover, J Segura-de la Morena, ... Endocrinología y Nutrición 61 (9), e25-e43, 2014 | 449 | 2014 |
Current level of glycaemic control and its associated factors in patients with type 2 diabetes across Europe: data from the PANORAMA study P de Pablos‐Velasco, KG Parhofer, C Bradley, E Eschwège, ... Clinical endocrinology 80 (1), 47-56, 2014 | 283 | 2014 |
Documento de información y consenso para la detección y manejo de la enfermedad renal crónica R García-Maset, J Bover, JS de la Morena, MG Diezhandino, JC del Hoyo, ... Nefrologia 42 (3), 233-264, 2022 | 210 | 2022 |
Consensus document for the detection and management of chronic kidney disease G de Redactores, A Martínez-Castelao, JL Górriz-Teruel, J Bover-Sanjuán, ... Nefrología (English Edition) 34 (2), 243-262, 2014 | 182 | 2014 |
Bone mineral metabolism is normal in non-insulin-dependent diabetes mellitus M Sosa, M Dominguez, MC Navarro, MC Segarra, D Hernandez, ... Journal of diabetes and its complications 10 (4), 201-205, 1996 | 180 | 1996 |
Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: A 6-month prospective study SM Webb, X Badia, NL Surinach, R Astorga, P Benito, M Catalá, ... European Journal of Endocrinology 155 (2), 269-277, 2006 | 164 | 2006 |
Predictors of Quality of Life and Other Patient-Reported Outcomes in the PANORAMA Multinational Study of People With Type 2 Diabetes C Bradley, E Eschwège, P de Pablos-Velasco, KG Parhofer, D Simon, ... Diabetes care 41 (2), 267-276, 2018 | 139 | 2018 |
Prevalence and determinants of diabetes mellitus and glucose intolerance in a Canarian Caucasian population–comparison of the 1997 ADA and the 1985 WHO criteria. The Guía Study. PL De Pablos‐Velasco, FJ Martínez‐Martín, F Rodríguez‐Pérez, BJ Anía, ... Diabetic Medicine 18 (3), 235-241, 2001 | 135 | 2001 |
Obesity and cardiovascular disease AP Pérez, JY Munoz, VB Cortés, P de Pablos Velasco Public health nutrition 10 (10A), 1156-1163, 2007 | 115 | 2007 |
Quality of life and satisfaction with treatment in subjects with type 2 diabetes: results in Spain of the PANORAMA study P DePablos-Velasco, E Salguero-Chaves, J Mata-Poyo, B DeRivas-Otero, ... Endocrinología y Nutrición (English Edition) 61 (1), 18-26, 2014 | 90 | 2014 |
PANORAMA: a European study to evaluate quality of life and treatment satisfaction in patients with type-2 diabetes mellitus—study design C Bradley, P de Pablos-Velasco, KG Parhofer, E Eschwège, ... Primary care diabetes 5 (4), 231-239, 2011 | 73 | 2011 |
Significado clínico de la obesidad abdominal PL de Pablos Velasco, FJ Martínez Martín Endocrinología y nutrición 54 (5), 265-271, 2007 | 68 | 2007 |
Epidemiología de la diabetes tipo 2 en España A Goday, E Delgado, FD Cadórniga, P De Pablos, JA Vázquez, E Soto Endocrinología y Nutrición 49 (4), 113-126, 2002 | 64 | 2002 |
Comparison of insulin glargine and liraglutide added to oral agents in patients with poorly controlled type 2 diabetes D D'Alessio, HU Häring, B Charbonnel, P de Pablos‐Velasco, ... Diabetes, Obesity and Metabolism 17 (2), 170-178, 2015 | 61 | 2015 |
Nateglinide improves early insulin secretion and controls postprandial glucose excursions in a prediabetic population C Saloranta, C Guitard, E Pecher, P de Pablos-Velasco, K Lahti, P Brunel, ... Diabetes Care 25 (12), 2141-2146, 2002 | 58 | 2002 |
Tratamiento de los pacientes con diabetes mellitus tipo 2 en atención primaria en España J Arroyo, X Badía, H de la Calle, J Díez, E Estmatjes, I Fernández, ... Medicina clínica 125 (5), 166-172, 2005 | 57 | 2005 |
N1-methylnicotinamide is a signalling molecule produced in skeletal muscle coordinating energy metabolism K Ström, D Morales-Alamo, F Ottosson, A Edlund, L Hjort, SW Jörgensen, ... Scientific reports 8 (1), 3016, 2018 | 56 | 2018 |